GlassScriptPhysician profile
Gary D Menszer
NPI 1275539751
$15,169.44
in general payments reported to CMS, 2019-2025
41 companies · $1,552 in 2025
The $1,552 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,393 · 2020: $1,341 · 2021: $2,222 · 2022: $3,094 · 2023: $2,931 · 2024: $1,636 · 2025: $1,552.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,120.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,119.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Silk Road Medical, INC. | $1,836.65 | 2020-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Medtronic, INC. | $1,398.73 | 2021-2025 | Hawkone, Protege Rx, Resolute Onyx |
| Janssen Pharmaceuticals, INC | $1,052.58 | 2019-2023 | Xarelto |
| Abiomed | $973.86 | 2019-2025 | Impella |
| Novartis Pharmaceuticals Corporation | $925.97 | 2019-2025 | |
| Pfizer INC. | $882.83 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $791.04 | 2019-2025 | Camzyos, Eliquis |
| Philips North America LLC | $680.93 | 2019-2024 | (Az7) Lasers, (Ck4) Mcot |
| Edwards Lifesciences Corporation | $552.77 | 2023-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Pascal, Sapien 3 Ultra Resilia |
| Sanofi-Aventis U.S. LLC | $522.14 | 2019-2024 | |
| Astrazeneca Pharmaceuticals LP | $516.96 | 2019-2025 | Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $504.74 | 2019-2025 | Jardiance |
| Amgen INC. | $405.44 | 2019-2024 | Repatha |
| Abbott Laboratories | $389.01 | 2021-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Mitraclip, Gallant |
| Medtronic Vascular, INC. | $386.56 | 2019-2020 |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $341.66 | 2021-2023 | Nexletol |
| Truvic Medical, INC. | $335.30 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $319.75 | 2019-2025 | Lifevest |
| Merck Sharp & Dohme LLC | $278.34 | 2022-2025 | Verquvo, Winrevair, Capvaxive |
| Boston Scientific Corporation | $248.88 | 2023-2025 | Enroute Transcarotid Stent, Farapulse, Ekosonic |
| Actelion Pharmaceuticals US, INC. | $243.11 | 2019-2024 | Uptravi, Opsumit |
| Amarin Pharma, INC. | $233.42 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $177.58 | 2021-2023 | |
| Biotronik INC. | $152.81 | 2024 | Orsiro Mission |
| Biosense Webster, INC. | $137.17 | 2023-2024 | Carto 3 |
| W. L. Gore & Associates, INC. | $129.85 | 2019 | |
| Shockwave Medical, INC | $128.06 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Baxter Healthcare | $92.45 | 2023-2025 | Hillrom - Carnation Ambulatory Monitor |
| Kowa Pharmaceuticals America, INC. | $78.10 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $68.24 | 2019 | |
| Gilead Sciences, INC. | $68.17 | 2019 | |
| Atricure, INC. | $64.13 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $56.94 | 2019 | |
| Livanova USA, INC. | $32.85 | 2023 | Lifesparc |
| Ge Healthcare | $31.93 | 2023-2025 | |
| Terumo Medical Corporation | $31.41 | 2019 | |
| Lundbeck LLC | $24.50 | 2020 | |
| Irhythm Technologies, INC. | $22.01 | 2023 | Zio Xt Patch |
| Kiniksa Pharmaceuticals International, Plc | $19.43 | 2024 | Arcalyst |
| Scpharmaceuticals INC. | $16.60 | 2025 | |
| Kestra Medical Technology Services, INC. | $16.54 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Menszer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.